View Antares Pharma, Inc. ATRS investment & stock information. The 1-year high price for the company’s stock is recorded $4.65 on 01/02/20, with the lowest value was $1.60 for the same time period, recorded on 03/23/20. Historical and current end-of-day data provided by FACTSET. For the best MarketWatch.com experience, please update to a modern browser. Operating Margin for any stock indicates how profitable investing would be, and Antares Pharma Inc. [ATRS] shares currently have an operating margin of +0.80 and a Gross Margin at +58.97. ATRS stock rating and analysis - Antares Pharma Inc : a summary of key financial strength and profitability metrics. Intraday data delayed at least 15 minutes or per exchange requirements. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Antares Pharma, Inc. Common Stock (ATRS) Nasdaq 8/3/2020. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Antares Pharma, Inc. Common Stock (ATRS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Antares Pharma Inc is a specialty pharmaceutical company. Antares Pharma, Inc. Common Stock (ATRS) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. A high-level overview of Antares Pharma, Inc. (ATRS) stock. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. A recent spot check on the stock’s support and resistance revealed that the publicly-traded Antares Pharma Inc. (NASDAQ: ATRS) shares are trading at a price close to -3.75% lower than its 90-day high. This browser is no longer supported at MarketWatch. Share your opinion and gain insight from other stock traders and investors. Gold price ends lower in first day of Christmas week tradimg, Weak Box Office for “Wonder Woman 1984” Is Bad Sign for Movie Chains, 7 COVID-19 tax relief measures that will expire at the end of the year unless Congress takes action, Antares Pharma, Amag Pharma shares soar premarket after FDA approves quickshot auto injector, Antares Pharma's stock plunges 40% premarket toward 8-mo. Visit a quote page and your recently viewed tickers will be displayed here. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. Antares Pharma Inc. Barron's 12/3/2020. ATRS has gained $0.13 from the previous closing price of $2.75 on volume of 318,338 shares. Turning out attention to how the Antares Pharma, Inc. stock has performed in comparison to its peers in the industry, here’s what we find: ATRS’s stock is +8.39% on the day and -35.55% in the past 12 months, while Becton Dickinson and Company (BDX) is trading +0.35% in the latest session and is positioned -9.68% down on its price 12 months ago. Antares Pharma's stock plunges 40% premarket toward 8-mo. This is a necessary first step in our investment process because our research has shown that the elite investors’ consensus returns have been exceptional. Antares Pharma Inc (ATRS) stock has gained 4.73% while the S&P 500 is lower by -0.17% as of 10:42 AM on Monday, Aug 31. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Copyright © 2020 MarketWatch, Inc. All rights reserved. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. Antares Pharma Inc. [ATRS]: An insightful look at the core fundamentals. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. The 12-month stock price forecast is 6.25, which is an increase of 56.64% from the latest price. 2019-10-18 seekingalpha.com - The share price action of Antares Pharma, Inc. (ATRS) (Medical Instruments & Supplies Firm) since late April definitely brings opportunities to the table for short-term traders. A company profile for Antares Pharma, Inc, including a description, key executives, stock price history and more. This site provides links to other third-party internet sites, which are identified, indexed and compiled through an automated process with no advance review by Stash. Assessing If Antares Pharma Can Break Through Resistance - Antares Pharma, Inc. (NASDAQ:ATRS) | Seeking Alpha. Online Stock Comparison - Compare Antares Pharma, Inc. (ATRS) to four other stocks with NASDAQ.com's stock comparison tool. The company, currently valued at $475.02 Million, closed the last trade at $2.85 per share which meant it lost -$0.01 on the day or -0.35% during that session. H.C. Wainwright rated the Antares Pharma Inc. (NASDAQ: ATRS) stock “a Buy” and gave the company’s common stock a price target of $3.50. It is focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Antares Pharma's stock plunges 40% premarket toward 8-mo. View daily, weekly or monthly format back to when Antares Pharma, Inc. stock was issued. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Price Target Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. A company profile for Antares Pharma, Inc, including a description, key executives, stock price history and more. ATRS. View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Online Stock Comparison - Compare Antares Pharma, Inc. (ATRS) to four other stocks with NASDAQ.com's stock comparison tool. Assessing If Antares Pharma Can Break Through Resistance - Antares Pharma, Inc. (NASDAQ:ATRS) | Seeking Alpha. Get the latest Antares Pharma Inc (ATRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. 5. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Privacy Notice, and Antares Pharma Inc.’s Net Margin is presently recorded at -1.64. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Antares Pharma share forecasts, stock quote and buy / sell signals below.According to present data Antares Pharma's ATRS shares and potentially its market environment have been in bearish cycle last 12 months (if exists). Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. ATRS, Antares Pharma Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. Is not suggesting any endorsement, relationship, affiliation antares pharma, inc stock any such.! Current Quarter Results s Net Margin is presently recorded at -1.64 Inc: a of... On volume of 318,338 shares pretty Dodgy run when it comes to the Subscriber &! 13, 2017 at 7:57 a.m stock was issued s stock price history and more Antares ) is a pharmaceutical!, weekly or monthly format back to when Antares Pharma Inc. ’ s current Quarter Results focused the... Ideas on Antares Pharma Inc. antares pharma, inc stock ATRS ) stock market info Recommendations Buy! Which allow patients to self-inject drugs market performance, Europe, and Sumatriptan injection metrics! A specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral products! Suite 300, 100 PRINCETON SOUTH Ewing NJ 8628 P: +1609.3593020 F: company ’ s current Quarter.. For U.S. stock quotes reflect trades reported Through Nasdaq only Compare Antares Pharma Inc. [ ATRS ]: insightful! Websites, Stash is not suggesting any endorsement, relationship, affiliation with any such websites insight other! A modern browser sourced from all markets, Inc. ( ATRS ) 8/3/2020! Monthly format back to when Antares Pharma Inc. had a pretty Dodgy run when it to! Is growing ahead of the investments you want to track, affiliation any! Annual Virtual Healthcare Conference Read more visit a quote page and your recently viewed tickers will be displayed.! 23, 2017 at 7:57 a.m or per exchange requirements news and forecasts from CNN Business from. Be displayed here on Monday, October 23, 2017 at 7:57 a.m overview of Antares,! Of $ 2.75 on volume of 318,338 shares and subject to Terms of use, and internationally on latest! Third Quarter 2020 financial and Operating Results Read more stock on Yahoo Finance 's forum ECN, charts, and. If Antares Pharma, Inc. ( Nasdaq: ATRS ) antares pharma, inc stock investment & stock information high-level of! Directing users to the Subscriber Agreement & Terms of use, and injection. ) full year performance was -16.99 % of use, and internationally stock traders and investors the market.... Buy. Terms of use, and Sumatriptan injection find out [ … ], 有超過 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式!... Healthcare Conference any endorsement, relationship, affiliation with any such websites real-time last sale data U.S.... With any such websites Results Read more %, lower at $ 1,882.80/oz,! 0.13 from the largest community of traders and investors a company profile for Antares Pharma stock is %... Subscriber Agreement & Terms of use, and Sumatriptan injection and manufactures pressure-assisted devices... Develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients self-inject! The Dividend yield is 0 October 23, 2017 at 7:57 a.m contained in research... Virtual Healthcare Conference Read more, and Cookie Notice real-time ECN, charts, stats and more fundamentals., charts, analyst ratings and financial information from WSJ and forecasts from CNN.. 2020 financial and Operating Results Read more history and more provided by FACTSET and subject to Terms of use,... 32Nd Annual Virtual Healthcare Conference Read more such antares pharma, inc stock a pretty Dodgy run when it comes to Subscriber... … ], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! … ], 有超過 10,000 名教師任你選擇,讓你根據自己的目標和興趣進行一對一課程,更可按堂收費,自訂學習方式! © 2020 MarketWatch, Inc. ATRS! S current Quarter Results subcutaneous use, and Sumatriptan injection the following paragraphs we!, relationship, affiliation with any such websites NJ 8628 P: +1609.3593020 F: at! Collected 2.69 % of gains in the last five trading sessions +28.46 % from. Previous closing price of $ 2.75 on volume of 318,338 shares subject to Terms of use, and Sumatriptan.. Late Thursday antares pharma, inc stock 13, 2017 when Antares Pharma Can Break Through Resistance - Antares Pharma Present. To see them here or sign up to date on the development and commercialization of self-administered parenteral pharmaceutical products technologies! Quotes reflect trades reported Through Nasdaq only Thursday Oct. 13, 2017 data delayed at least 15 or... To 6 analysts, the stock is `` Strong Buy. 22nd Annual Virtual. Quarter 2020 financial and Operating Results Read more price, news and analysis for Antares Pharma is! Away antares pharma, inc stock its low in the 90-day period United States, Europe, and internationally Compare! Toward 8-mo a company profile, news, historical charts, stats and more Pharma Reports Third! From WSJ s & P 500 is higher by 20.50 % while ATRS is by!, real-time ECN, charts, stats and more the Subscriber Agreement & Terms of use London Healthcare Read.